BSE filing, NSE: LOTUSEYE. Summary written from the filing by ALFA Finder's alert engine.
Lotus Eye Hospital and Institute Ltd: key numbers
- Share price
- ₹110.00
- Market cap
- ₹228.8 Cr
- Revenue (annual)
- ₹53.71 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- 1532.2×Sector 52.3×
- Promoter holding
- 40.14%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lotus Eye Hospital and Institute Ltd
All →Lotus Eye Hospital and Institute Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with Regulation 31(1)(b) of SEBI LODR.
Lotus Eye Hospital and Institute Annual General Meeting
Lotus Eye Hospital And Institute Limited held its 29th Annual General Meeting on September 23, 2026, via video conferencing to discuss company operations and financial highlights.
Lotus Eye Hospital and Institute Annual General Meeting
Lotus Eye Hospital and Institute Limited will hold its 29th Annual General Meeting on September 23, 2026. The company has dispatched the Notice and Annual Report for FY 2025-26.
Lotus Eye Hospital and Institute Capacity Expansion
Lotus Eye Hospital and Institute Limited launched 'Lotus Optique', a new optical retail store in Coimbatore. The facility integrates professional eye care with quality eyewear products.
Lotus Eye Hospital and Institute Q1 FY27 Results: Net Profit ₹0.6 Cr, Up 20.0% YoY
Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹17.1 Cr (+26.7% YoY) and net profit of ₹0.6 Cr (+20.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.6 Cr · +20.0% YoY
Lotus Eye Hospital and Institute Board Meeting Date
Lotus Eye Hospital and Institute will hold a board meeting on August 10, 2026, to approve the company's standalone unaudited financial results for the June quarter.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM